Clinical Trial Update: Nebulized Beclometasone Dipropionate Improves Nasal Patency in Children With Allergic Rhinitis [Phase 4]

View source ↗

Summary

Phase 4 trial update showing that nebulized beclometasone dipropionate improves nasal patency in children with allergic rhinitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Beclometasone Dipropionate (nebulized) (Beclometasone dipropionate)

Snippet

Sponsor: Stefania La Grutta, MD | Conditions: Allergic Rhinitis | Phase 4 | Status: COMPLETED